EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie

Risk of residual neoplasia after a noncurative colorectal endoscopic submucosal dissection for malignant lesions: a multinational study

João Santos-Antunes iD, Mathieu Pioche, Felipe Ramos-Zabala iD, Paolo Cecinato iD, Francisco J Gallego Rojo, Pedro Barreiro, Catarina Félix iD, Sandro Sferrazza, Frieder Berr, Andrej Wagner, Arnaud Lemmers iD, Mariana Figueiredo Ferreira und 12 weitere

Endoscopy · 01.03.2023 · 55 (03) · 235-244

DOI: 10.1055/a-1906-8000 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.03.2023. Verfasst von João Santos-Antunes und 23 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Faculty of Medicine, Centro Hospitalar Universitário S. João, Porto, Portugal. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Colorectal Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endoscopic submucosal dissection (ESD) in colorectal lesions is technically demanding and a significant rate of noncurative procedures is expected. We aimed to assess the rate of residual lesions after a noncurative ESD for colorectal cancer (CRC) and to establish predictive scores to be applied in the clinical setting.

Methods

Retrospective multicenter analysis of consecutive colorectal ESDs. Patients with noncurative ESDs performed for the treatment of CRC lesions submitted to complementary surgery or with at least one follow-up endoscopy were included.

Results

From 2255 colorectal ESDs, 381 (17 %) were noncurative, and 135 of these were performed in CRC lesions. A residual lesion was observed in 24 patients (18 %). Surgery was performed in 96 patients and 76 (79 %) had no residual lesion in the colorectal wall or in the lymph nodes. The residual lesion rate for sm1 cancers was 0 %, and for > sm1 cancers was also 0 % if no other risk factors were present. Independent risk factors for lymph node metastasis were poor differentiation and lymphatic permeation (NC-Lymph score). Risk factors for the presence of a residual lesion in the wall were piecemeal resection, poor differentiation, and positive/indeterminate vertical margin (NC-Wall score).

Conclusions

Lymphatic permeation or poor differentiation warrant surgery owing to their high risk of lymph node metastasis, mainly in > sm1 cancers. In the remaining cases, en bloc and R0 resections resulted in a low risk of residual lesions in the wall. Our scores can be a useful tool for the management of patients who undergo noncurative colorectal ESDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionColorectal NeoplasmsHumansLymphatic MetastasisEndoscopyRetrospective StudiesNeoplasm, ResidualTreatment Outcome

Autor:innen und Institutionen

  • Gastroenterology Department, Faculty of Medicine, Centro Hospitalar Universitário S. João, Porto, Portugal.
  • Ipatimup/i3S (Instituto de Investigação e Inovação em Saúde da Universidade do Porto), Porto, Portugal.
  • Department of Hepatology and Gastroenterology, Edouard Herriot Hospital, Lyon, France.
  • Department of Gastroenterology, Department of Clinical Medical Sciences, Hospital Universitario HM Montepríncipe, HM Hospitales, Universidad San Pablo-CEU, CEU Universities Madrid, Madrid, Spain.
  • Gastroenterology and Digestive Endoscopy Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Gastroenterology Department, Hospital de Poniente, Almería, Spain.

ORCID-Profile: João Santos-Antunes, Felipe Ramos-Zabala, Paolo Cecinato, Catarina Félix, Arnaud Lemmers, Eduardo Albéniz, Ricardo Küttner-Magalhães, Rui Morais, Sunil Gupta

Zitieren

APA

Santos-Antunes, J., Pioche, M., Ramos-Zabala, F., Cecinato, P., Gallego Rojo, F. J., Barreiro, P., Félix, C., Sferrazza, S., Berr, F., Wagner, A., Lemmers, A., Figueiredo Ferreira, M., Albéniz, E., Uchima, H., Küttner-Magalhães, R., Fernandes, C., Morais, R., Gupta, S., Martinho-Dias, D., …, & Macedo, G. (2023). Risk of residual neoplasia after a noncurative colorectal endoscopic submucosal dissection for malignant lesions: a multinational study. Endoscopy, 55(03), 235-244. https://doi.org/10.1055/a-1906-8000

Vancouver

Santos-Antunes J, Pioche M, Ramos-Zabala F, Cecinato P, Gallego Rojo FJ, Barreiro P, et al. Risk of residual neoplasia after a noncurative colorectal endoscopic submucosal dissection for malignant lesions: a multinational study. Endoscopy. 2023;55(03):235-244. doi:10.1055/a-1906-8000

BibTeX
@article{SantosAntunes2023,
  author = {Santos-Antunes, João and Pioche, Mathieu and Ramos-Zabala, Felipe and Cecinato, Paolo and Gallego Rojo, Francisco J and Barreiro, Pedro and Félix, Catarina and Sferrazza, Sandro and Berr, Frieder and Wagner, Andrej and Lemmers, Arnaud and Figueiredo Ferreira, Mariana and Albéniz, Eduardo and Uchima, Hugo and Küttner-Magalhães, Ricardo and Fernandes, Carlos and Morais, Rui and Gupta, Sunil and Martinho-Dias, Daniel and Rios, Elisabete and Faria-Ramos, Isabel and Marques, Margarida and Bourke, Michael J and Macedo, Guilherme},
  title = {Risk of residual neoplasia after a noncurative colorectal endoscopic submucosal dissection for malignant lesions: a multinational study},
  journal = {Endoscopy},
  year = {2023},
  volume = {55},
  number = {03},
  pages = {235--244},
  doi = {10.1055/a-1906-8000}
}
Kostenlos starten →